RMTI ROCKWELL MEDICAL, INC.


$ 0.85 $ -0.02 (-1.76 %)    

Wednesday, 19-Nov-2025 15:47:12 EST
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
$ 0.88
$ 0.85 x 100
$ 0.85 x 200
$ 0.84 - $ 0.89
$ 0.78 - $ 2.52
364,617
na
33.88M
$ 2.05
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-maintains-buy-on-rockwell-medical-lowers-price-target-to-25

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Rockwell Medical (NASDAQ:RMTI) with a Buy and lowers the price ...

 rockwell-medical-affirms-fy2025-sales-guidance-of-65000m-70000m-vs-68374m-est

Rockwell Medical (NASDAQ:RMTI) affirms FY2025 sales outlook from $65.000 million-$70.000 million to $65.000 million-$70.000 mil...

 rockwell-medical-q3-sales-15927m-miss-16241m-estimate

Rockwell Medical (NASDAQ:RMTI) reported quarterly sales of $15.927 million which missed the analyst consensus estimate of $16.2...

 rockwell-medical-affirms-fy2025-sales-guidance-of-65000m-70000m-vs-68229m-est

Rockwell Medical (NASDAQ:RMTI) affirms FY2025 sales outlook from $65.000 million-$70.000 million to $65.000 million-$70.000 mil...

 rockwell-medical-q2-adj-eps-001-beats-005-estimate-sales-16071m-miss-16332m-estimate

Rockwell Medical (NASDAQ:RMTI) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0....

 rockwell-medical-affirms-fy2025-sales-guidance-of-6500m-7000m-vs-6742m-est

GUIDANCERockwell confirms its 2025 annual guidance as follows: 2025 Annual GuidanceNet Sales$65.0M to $70.0MGross Margin16% to ...

 hc-wainwright--co-maintains-buy-on-rockwell-medical-lowers-price-target-to-3

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Rockwell Medical (NASDAQ:RMTI) with a Buy and lowers the price ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION